This site, authorized by editors of JAMA, contains supplementary information to the COX-2 inhibitor drug review published that were unable to be fully presented and described in print format for the study "Adverse Effects of Cyclooxygenase-2 Inhibitors on Renal and Arrhythmia Events: Meta-Analysis of Randomized Trials" (JAMA 2006, by Zhang JJ, Ding EL, Song Y.).
You may browse the available supplementary information using the sidebar. However, a few key pages are described below:
1) Press Release of the article from Harvard School of Public Health.
2) Forest plots of Rofecoxib, Celecoxib, Valdecoxib+Parecoxib, Etoricoxib, and Lumiracoxib available for most endpoints.
3) Tests for Publication Bias. Funnel plots, Begg's Tests, Egger's Tests available for certain endpoints.
4) Interested readers may also make short requests for special figures or further analyses, although volume of requests will determine response time.
Note: Please try to bookmark the primary portal http://www.Cox2DrugReview.org, rather than subpages. Thank you.
Supplemental results to the large COX-2 inhibitor review in JAMA: "Adverse Effects of Cyclooxygenase-2 Inhibitors on Renal and Arrhythmia Events: Meta-Analysis of Randomized Trials"